{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "28692651", "DateCompleted": {"Year": "2017", "Month": "09", "Day": "25"}, "DateRevised": {"Year": "2024", "Month": "02", "Day": "16"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2017", "Month": "07", "Day": "10"}], "ELocationID": ["e0180212", "10.1371/journal.pone.0180212"], "Journal": {"ISSN": "1932-6203", "JournalIssue": {"Volume": "12", "Issue": "7", "PubDate": {"Year": "2017"}}, "Title": "PloS one", "ISOAbbreviation": "PLoS One"}, "ArticleTitle": "Effects of clinical and environmental factors on bronchoalveolar antibody responses to Pneumocystis jirovecii: A prospective cohort study of HIV+ patients.", "Pagination": {"StartPage": "e0180212", "MedlinePgn": "e0180212"}, "Abstract": {"AbstractText": ["Humoral immunity plays an important role against Pneumocystis jirovecii infection, yet clinical and environmental factors that impact bronchoalveolar antibody responses to P. jirovecii remain uncertain.", "From October 2008-December 2011 we enrolled consecutive HIV-infected adults admitted to San Francisco General Hospital (SFGH) who underwent bronchoscopy for suspected Pneumocystis pneumonia (PCP). We used local air quality monitoring data to assign ozone, nitrogen dioxide, and fine particulate matter exposures within 14 days prior to hospital admission. We quantified serum and bronchoalveolar lavage fluid (BALF) antibody responses to P. jirovecii major surface glycoprotein (Msg) recombinant constructs using ELISA. We then fit linear regression models to determine whether PCP and ambient air pollutants were associated with bronchoalveolar antibody responses to Msg.", "Of 81 HIV-infected patients enrolled, 47 (58%) were diagnosed with current PCP and 9 (11%) had a prior history of PCP. The median CD4+ count was 51 cells/\u03bcl (IQR 15-129) and 44% were current smokers. Serum antibody responses to Msg were statistically significantly predictive of BALF antibody responses, with the exception of IgG responses to MsgC8 and MsgC9. Prior PCP was associated with increased BALF IgA responses to Msg and current PCP was associated with decreased IgA responses. For instance, among patients without current PCP, those with prior PCP had a median 73.2 U (IQR 19.2-169) IgA response to MsgC1 compared to a 5.00 U (3.52-12.6) response among those without prior PCP. Additionally, current PCP predicted a 22.5 U (95%CI -39.2, -5.82) lower IgA response to MsgC1. Ambient ozone within the two weeks prior to hospital admission was associated with decreased BALF IgA responses to Msg while nitrogen dioxide was associated with increased IgA responses.", "PCP and ambient air pollutants were associated with BALF IgA responses to P. jirovecii in HIV-infected patients evaluated for suspected PCP."]}, "AuthorList": [{"Identifier": ["0000-0001-6177-7436"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, California, United States of America."}, {"Identifier": [], "Affiliation": "Division of Pediatric Pulmonology, University of California, San Francisco, California, United States of America."}], "LastName": "Blount", "ForeName": "Robert J", "Initials": "RJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Infectious Diseases, University of Cincinnati, Cincinnati, Ohio, United States of America."}, {"Identifier": [], "Affiliation": "Veterans Administration Medical Center, Cincinnati, Ohio, United States of America."}], "LastName": "Daly", "ForeName": "Kieran R", "Initials": "KR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "HIV/AIDS Division, San Francisco General Hospital, University of California, San Francisco, California, United States of America."}], "LastName": "Fong", "ForeName": "Serena", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "HIV/AIDS Division, San Francisco General Hospital, University of California, San Francisco, California, United States of America."}], "LastName": "Chang", "ForeName": "Emily", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "HIV/AIDS Division, San Francisco General Hospital, University of California, San Francisco, California, United States of America."}], "LastName": "Grieco", "ForeName": "Katherine", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "HIV/AIDS Division, San Francisco General Hospital, University of California, San Francisco, California, United States of America."}], "LastName": "Greene", "ForeName": "Meredith", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "HIV/AIDS Division, San Francisco General Hospital, University of California, San Francisco, California, United States of America."}], "LastName": "Stone", "ForeName": "Stephen", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, California, United States of America."}, {"Identifier": [], "Affiliation": "Environmental Health Sciences, University of California, Berkeley, California, United States of America."}], "LastName": "Balmes", "ForeName": "John", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Department of Infection and Population Health, Institute of Epidemiology and Healthcare, University College London, London, United Kingdom."}, {"Identifier": [], "Affiliation": "Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom."}], "LastName": "Miller", "ForeName": "Robert F", "Initials": "RF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Infectious Diseases, University of Cincinnati, Cincinnati, Ohio, United States of America."}, {"Identifier": [], "Affiliation": "Veterans Administration Medical Center, Cincinnati, Ohio, United States of America."}], "LastName": "Walzer", "ForeName": "Peter D", "Initials": "PD"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, California, United States of America."}, {"Identifier": [], "Affiliation": "HIV/AIDS Division, San Francisco General Hospital, University of California, San Francisco, California, United States of America."}], "LastName": "Huang", "ForeName": "Laurence", "Initials": "L"}], "GrantList": [{"GrantID": "K23 ES025807", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "T32 HL007185", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "R01 HL128156", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "K24 HL087713", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "P30 AI027763", "Acronym": "AI", "Agency": "NIAID NIH HHS", "Country": "United States"}, {"GrantID": "R01 HL090335", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "F32 ES022582", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "PLoS One", "NlmUniqueID": "101285081", "ISSNLinking": "1932-6203"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Air Pollutants"}, {"RegistryNumber": "0", "NameOfSubstance": "Fungal Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Immunoglobulin A"}, {"RegistryNumber": "0", "NameOfSubstance": "Membrane Glycoproteins"}, {"RegistryNumber": "151472-24-1", "NameOfSubstance": "GPA protein, Pneumocystis carinii sp."}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": ["analysis"], "DescriptorName": "Air Pollutants"}, {"QualifierName": ["immunology"], "DescriptorName": "Antibody Formation"}, {"QualifierName": ["immunology", "microbiology", "pathology"], "DescriptorName": "Bronchi"}, {"QualifierName": [], "DescriptorName": "Bronchoalveolar Lavage Fluid"}, {"QualifierName": [], "DescriptorName": "Environment"}, {"QualifierName": [], "DescriptorName": "Environmental Exposure"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["immunology"], "DescriptorName": "Fungal Proteins"}, {"QualifierName": ["complications", "immunology"], "DescriptorName": "HIV Infections"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["blood"], "DescriptorName": "Immunoglobulin A"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["immunology"], "DescriptorName": "Membrane Glycoproteins"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["immunology"], "DescriptorName": "Pneumocystis carinii"}, {"QualifierName": ["complications", "diagnosis", "immunology", "microbiology"], "DescriptorName": "Pneumonia, Pneumocystis"}, {"QualifierName": [], "DescriptorName": "Prospective Studies"}, {"QualifierName": ["immunology", "microbiology", "pathology"], "DescriptorName": "Pulmonary Alveoli"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}], "CoiStatement": "<b>Competing Interests: </b>The authors have declared that no competing interests exist."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Gajdusek DC. Pneumocystis carinii; etiologic agent of interstitial plasma cell pneumonia of premature and young infants. Pediatrics. 1957;19(4 Pt 1):543\u201365. Epub 1957/04/01. .", "ArticleIdList": ["13419426"]}, {"Citation": "Huang L, Cattamanchi A, Davis JL, den Boon S, Kovacs J, Meshnick S, et al.\nHIV-associated Pneumocystis pneumonia. Proc Am Thorac Soc. 2011;8(3):294\u2013300. doi: 10.1513/pats.201009-062WR ;", "ArticleIdList": ["10.1513/pats.201009-062WR", "PMC3132788", "21653531"]}, {"Citation": "Walzer PD, Rutledge ME. Humoral immunity in experimental Pneumocystis carinii infection. I. Serum and bronchial lavage fluid antibody responses in rats. The Journal of laboratory and clinical medicine. 1981;97(6):820 ;", "ArticleIdList": ["7014742"]}, {"Citation": "Harmsen AG, Stankiewicz M. T cells are not sufficient for resistance to Pneumocystis carinii pneumonia in mice. The Journal of protozoology. 1991;38(6):44S .", "ArticleIdList": ["1687826"]}, {"Citation": "Gigliotti F, Haidaris CG, Wright TW, Harmsen AG. Passive intranasal monoclonal antibody prophylaxis against murine Pneumocystis carinii pneumonia. Infect Immun. 2002;70(3):1069\ndoi: 10.1128/IAI.70.3.1069-1074.2002 .", "ArticleIdList": ["10.1128/IAI.70.3.1069-1074.2002", "PMC127758", "11854184"]}, {"Citation": "Furuta T, Ueda K, Fujiwara K, Yamanouchi K. Cellular and humoral immune responses of mice subclinically infected with Pneumocystis carinii. Infect Immun. 1985;47(2):544 .", "ArticleIdList": ["PMC263206", "3871426"]}, {"Citation": "Empey KM, Hollifield M, Schuer K, Gigliotti F, Garvy BA. Passive immunization of neonatal mice against Pneumocystis carinii f. sp. muris enhances control of infection without stimulating inflammation. Infect Immun. 2004;72(11):6211\ndoi: 10.1128/IAI.72.11.6211-6220.2004 ;", "ArticleIdList": ["10.1128/IAI.72.11.6211-6220.2004", "PMC523030", "15501746"]}, {"Citation": "Zheng M, Shellito JE, Marrero L, Zhong Q, Julian S, Ye P, et al.\nCD4+ T cell-independent vaccination against Pneumocystis carinii in mice. J Clin Invest. 2001;108(10):1469\ndoi: 10.1172/JCI13826 .", "ArticleIdList": ["10.1172/JCI13826", "PMC209424", "11714738"]}, {"Citation": "Gigliotti F, Harmsen AG. Pneumocystis carinii host origin defines the antibody specificity and protective response induced by immunization. J Infect Dis. 1997;176(5):1322 .", "ArticleIdList": ["9359734"]}, {"Citation": "Wells J, Haidaris CG, Wright TW, Gigliotti F. Active immunization against Pneumocystis carinii with a recombinant P. carinii antigen. Infect Immun. 2006;74(4):2446\ndoi: 10.1128/IAI.74.4.2446-2448.2006 ;", "ArticleIdList": ["10.1128/IAI.74.4.2446-2448.2006", "PMC1418926", "16552076"]}, {"Citation": "Wells J, Haidaris CG, Wright TW, Gigliotti F. Complement and Fc function are required for optimal antibody prophylaxis against Pneumocystis carinii pneumonia. Infect Immun. 2006;74(1):390\ndoi: 10.1128/IAI.74.1.390-393.2006 ;", "ArticleIdList": ["10.1128/IAI.74.1.390-393.2006", "PMC1346672", "16368994"]}, {"Citation": "Marcotte H, Levesque D, Delanay K, Bourgeault A, de la Durantaye R, Brochu S, et al. Pneumocystis carinii infection in transgenic B cell-deficient mice. J Infect Dis. 1996;173(4):1034 .", "ArticleIdList": ["8603947"]}, {"Citation": "Dittrich AM, Schulze I, Magdorf K, Wahn V, Wahn U. X-linked agammaglobulinaemia and Pneumocystis carinii pneumonia\u2014an unusual coincidence? European journal of pediatrics. 2003;162(6):432.", "ArticleIdList": ["12700897"]}, {"Citation": "Alibrahim A, Lepore M, Lierl M, Filipovich A, Assaad A. Pneumocystis carinii pneumonia in an infant with X-linked agammaglobulinemia. J Allergy Clin Immunol. 1998;101(4 Pt 1):552 ;", "ArticleIdList": ["9564810"]}, {"Citation": "Cetin E, Lee EY. Pneumocystis carinii pneumonia in an infant with hypogammaglobulinemia. Pediatr Radiol. 2007;37(3):329\ndoi: 10.1007/s00247-006-0375-z .", "ArticleIdList": ["10.1007/s00247-006-0375-z", "17165040"]}, {"Citation": "Skalski JH, Kottom TJ, Limper AH. Pathobiology of Pneumocystis pneumonia: life cycle, cell wall and cell signal transduction. FEMS Yeast Res. 2015;15(6). doi: 10.1093/femsyr/fov046 .", "ArticleIdList": ["10.1093/femsyr/fov046", "26071598"]}, {"Citation": "Mei Q, Turner RE, Sorial V, Klivington D, Angus CW, Kovacs JA. Characterization of major surface glycoprotein genes of human Pneumocystis carinii and high-level expression of a conserved region. Infect Immun. 1998;66(9):4268 .", "ArticleIdList": ["PMC108515", "9712777"]}, {"Citation": "Daly KR, Fichtenbaum CJ, Tanaka R, Linke MJ, O'Bert R, Thullen TD, et al.\nSerologic responses to epitopes of the major surface glycoprotein of Pneumocystis jiroveci differ in human immunodeficiency virus-infected and uninfected persons. J Infect Dis. 2002;186(5):644\ndoi: 10.1086/341565 ;", "ArticleIdList": ["10.1086/341565", "12195351"]}, {"Citation": "Daly KR, Koch J, Levin L, Walzer PD. Enzyme-linked immunosorbent assay and serologic responses to Pneumocystis jiroveci. Emerg Infect Dis. 2004;10(5):848\ndoi: 10.3201/eid1005.030497 .", "ArticleIdList": ["10.3201/eid1005.030497", "PMC3323219", "15200818"]}, {"Citation": "Daly KR, Koch JV, Shire NJ, Levin L, Walzer PD. Human immunodeficiency virus-infected patients with prior Pneumocystis pneumonia exhibit increased serologic reactivity to several major surface glycoprotein clones. Clin Vaccine Immunol. 2006;13(10):1071\u20138. doi: 10.1128/CVI.00140-06 ;", "ArticleIdList": ["10.1128/CVI.00140-06", "PMC1595325", "17028210"]}, {"Citation": "Tomas AL, Cardoso F, Esteves F, Matos O. Serological diagnosis of pneumocystosis: production of a synthetic recombinant antigen for immunodetection of Pneumocystis jirovecii. Sci Rep. 2016;6:36287\ndoi: 10.1038/srep36287 .", "ArticleIdList": ["10.1038/srep36287", "PMC5099754", "27824115"]}, {"Citation": "Esteves F, Cale SS, Badura R, de Boer MG, Maltez F, Calderon EJ, et al.\nDiagnosis of Pneumocystis pneumonia: evaluation of four serologic biomarkers. Clin Microbiol Infect. 2015;21(4):379 e1\u201310. doi: 10.1016/j.cmi.2014.11.025 .", "ArticleIdList": ["10.1016/j.cmi.2014.11.025", "25630458"]}, {"Citation": "Daly KR, Huang L, Morris A, Koch J, Crothers K, Levin L, et al. Antibody response to Pneumocystis jirovecii major surface glycoprotein. Emerg Infect Dis. 2006;12(8):1231.", "ArticleIdList": ["PMC3291227", "16965702"]}, {"Citation": "Djawe K, Huang L, Daly KR, Levin L, Koch J, Schwartzman A, et al.\nSerum antibody levels to the Pneumocystis jirovecii major surface glycoprotein in the diagnosis of P. jirovecii pneumonia in HIV+ patients. PLoS One. 2010;5(12):e14259\ndoi: 10.1371/journal.pone.0014259 ;", "ArticleIdList": ["10.1371/journal.pone.0014259", "PMC3000336", "21151564"]}, {"Citation": "Blount RJ, Jarlsberg LG, Daly KR, Worodria W, Davis JL, Cattamanchi A, et al.\nSerologic responses to recombinant Pneumocystis jirovecii major surface glycoprotein among Ugandan patients with respiratory symptoms. PLoS One. 2012;7(12):e51545\ndoi: 10.1371/journal.pone.0051545 ;", "ArticleIdList": ["10.1371/journal.pone.0051545", "PMC3528778", "23284710"]}, {"Citation": "Alvaro-Meca A, Palomares-Sancho I, Diaz A, Resino R, De Miguel AG, Resino S. Pneumocystis pneumonia in HIV-positive patients in Spain: epidemiology and environmental risk factors. J Int AIDS Soc. 2015;18(1):19906 Epub 2015/05/23. doi: 10.7448/ias.18.1.19906 ;", "ArticleIdList": ["10.7448/ias.18.1.19906", "PMC4440874", "25997453"]}, {"Citation": "Djawe K, Levin L, Swartzman A, Fong S, Roth B, Subramanian A, et al.\nEnvironmental risk factors for Pneumocystis pneumonia hospitalizations in HIV patients. Clin Infect Dis. 2013;56(1):74\ndoi: 10.1093/cid/cis841 ;", "ArticleIdList": ["10.1093/cid/cis841", "PMC3571628", "23042978"]}, {"Citation": "Blount RJ, Djawe K, Daly KR, Jarlsberg LG, Fong S, Balmes J, et al.\nAmbient air pollution associated with suppressed serologic responses to Pneumocystis jirovecii in a prospective cohort of HIV-infected patients with Pneumocystis pneumonia. PLoS One. 2013;8(11):e80795\ndoi: 10.1371/journal.pone.0080795 ;", "ArticleIdList": ["10.1371/journal.pone.0080795", "PMC3827464", "24236202"]}, {"Citation": "Tipirneni R, Daly KR, Jarlsberg LG, Koch JV, Swartzman A, Roth BM, et al.\nHealthcare worker occupation and immune response to Pneumocystis jirovecii. Emerg Infect Dis. 2009;15(10):1590\u20137. doi: 10.3201/eid1510.090207 ;", "ArticleIdList": ["10.3201/eid1510.090207", "PMC2866396", "19861050"]}, {"Citation": "Jalil A, Moja P, Lambert C, Perol M, Cotte L, Livrozet JM, et al. Decreased production of local immunoglobulin A to Pneumocystis carinii in bronchoalveolar lavage fluid from human immunodeficiency virus-positive patients. Infect Immun. 2000;68(3):1054\u201360. Epub 2000/02/26. ;", "ArticleIdList": ["PMC97248", "10678907"]}, {"Citation": "Laursen AL, Jensen BN, Andersen PL. Local antibodies against Pneumocystis carinii in bronchoalveolar lavage fluid. European Respiratory Journal. 1994;7(4):679\u201385. doi: 10.1183/09031936.94.07040679\n", "ArticleIdList": ["10.1183/09031936.94.07040679", "8005248"]}, {"Citation": "Fei MW, Kim EJ, Sant CA, Jarlsberg LG, Davis JL, Swartzman A, et al.\nPredicting mortality from HIV-associated Pneumocystis pneumonia at illness presentation: an observational cohort study. Thorax. 2009;64(12):1070\u20136. doi: 10.1136/thx.2009.117846 ;", "ArticleIdList": ["10.1136/thx.2009.117846", "PMC2788120", "19825785"]}, {"Citation": "Du Rand IA, Blaikley J, Booton R, Chaudhuri N, Gupta V, Khalid S, et al.\nBritish Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE. Thorax. 2013;68\nSuppl 1:i1\u2013i44. doi: 10.1136/thoraxjnl-2013-203618 .", "ArticleIdList": ["10.1136/thoraxjnl-2013-203618", "23860341"]}, {"Citation": "Bishop LR, Kovacs JA. Quantitation of anti-Pneumocystis jiroveci antibodies in healthy persons and immunocompromised patients. J Infect Dis. 2003;187(12):1844\ndoi: 10.1086/375354 ;", "ArticleIdList": ["10.1086/375354", "12792860"]}, {"Citation": "Kelly MN, Shellito JE. Current understanding of Pneumocystis immunology. Future microbiology. 2010;5:43\ndoi: 10.2217/fmb.09.116 .", "ArticleIdList": ["10.2217/fmb.09.116", "PMC3702169", "20020829"]}, {"Citation": "Steele C, Shellito JE, Kolls JK. Immunity against the opportunistic fungal pathogenPneumocystis. Med Mycol. 2005;43(1):1\u201319. doi: 10.1080/13693780400015360\n", "ArticleIdList": ["10.1080/13693780400015360", "15712604"]}, {"Citation": "Djawe K, Daly KR, Vargas SL, Santolaya ME, Ponce CA, Bustamante R, et al.\nSeroepidemiological study of Pneumocystis jirovecii infection in healthy infants in Chile using recombinant fragments of the P. jirovecii major surface glycoprotein. Int J Infect Dis. 2010;14(12):e1060\u20136. doi: 10.1016/j.ijid.2010.07.003 ;", "ArticleIdList": ["10.1016/j.ijid.2010.07.003", "PMC2995006", "20926326"]}, {"Citation": "Vargas SL, Hughes WT, Santolaya ME, Ulloa AV, Ponce CA, Cabrera CE, et al.\nSearch for primary infection by Pneumocystis carinii in a cohort of normal, healthy infants. Clin Infect Dis. 2001;32(6):855\ndoi: 10.1086/319340 ;", "ArticleIdList": ["10.1086/319340", "11247708"]}, {"Citation": "Davis JL, Welsh DA, Beard CB, Jones JL, Lawrence GG, Fox MR, et al.\nPneumocystis colonisation is common among hospitalised HIV infected patients with non-Pneumocystis pneumonia. Thorax. 2008;63(4):329\u201334. doi: 10.1136/thx.2007.088104 .", "ArticleIdList": ["10.1136/thx.2007.088104", "18024536"]}, {"Citation": "Kim CS, Alexis NE, Rappold AG, Kehrl H, Hazucha MJ, Lay JC, et al.\nLung function and inflammatory responses in healthy young adults exposed to 0.06 ppm ozone for 6.6 hours. Am J Respir Crit Care Med. 2011;183(9):1215\u201321. doi: 10.1164/rccm.201011-1813OC ;", "ArticleIdList": ["10.1164/rccm.201011-1813OC", "PMC3114053", "21216881"]}, {"Citation": "Ward WO, Ledbetter AD, Schladweiler MC, Kodavanti UP. Lung transcriptional profiling: insights into the mechanisms of ozone-induced pulmonary injury in Wistar Kyoto rats. Inhal Toxicol. 2015;27\nSuppl 1:80\u201392. Epub 2015/12/17. doi: 10.3109/08958378.2014.954172 .", "ArticleIdList": ["10.3109/08958378.2014.954172", "26667333"]}, {"Citation": "Arjomandi M, Wong H, Donde A, Frelinger J, Dalton S, Ching W, et al.\nExposure to medium and high ambient levels of ozone causes adverse systemic inflammatory and cardiac autonomic effects. Am J Physiol Heart Circ Physiol. 2015;308(12):H1499\u2013509. doi: 10.1152/ajpheart.00849.2014 ;", "ArticleIdList": ["10.1152/ajpheart.00849.2014", "PMC4469877", "25862833"]}, {"Citation": "Miller DB, Ghio AJ, Karoly ED, Bell LN, Snow SJ, Madden MC, et al.\nOzone Exposure Increases Circulating Stress Hormones and Lipid Metabolites in Humans. Am J Respir Crit Care Med. 2016.  Epub 2016/01/09. doi: 10.1164/rccm.201508-1599OC .", "ArticleIdList": ["10.1164/rccm.201508-1599OC", "PMC5440058", "26745856"]}, {"Citation": "Jakab GJ, Spannhake EW, Canning BJ, Kleeberger SR, Gilmour MI. The effects of ozone on immune function. Environ Health Perspect. 1995;103 Suppl 2:77\u201389. Epub 1995/03/01. ;", "ArticleIdList": ["PMC1518840", "7614952"]}, {"Citation": "Ehrlich R, Silverstein E, Maigetter R, Fenters JD. Immunologic response in vaccinated mice during long-term exposure to nitrogen dioxide. Environ Res. 1975;10(2):217\u201323. Epub 1975/10/01. .", "ArticleIdList": ["1193034"]}, {"Citation": "Fujimaki H, Shimizu F, Kubota K. Suppression of antibody response in mice by acute exposure to nitrogen dioxide: In vitro study. Environ Res. 1981;26(2):490\u20136. http://dx.doi.org/10.1016/0013-9351(81)90224-3. ", "ArticleIdList": ["10.1016/0013-9351(81)90224-3", "7032905"]}, {"Citation": "Balchum OJ, Buckley RD, Sherwin R, Gardner M. Nitrogen Dioxide Inhalation And Lung Antibodies. Archives of Environmental Health: An International Journal. 1965;10(2):274\u20137. doi: 10.1080/00039896.1965.10663995", "ArticleIdList": ["10.1080/00039896.1965.10663995", "14232911"]}, {"Citation": "Hidekazu F, Fujio S. Effects of acute exposure to nitrogen dioxide on primary antibody response. Arch Environ Health. 1981;36(3):114\u20139. Epub 1981/05/01. .", "ArticleIdList": ["7018408"]}, {"Citation": "Chaney S, Blomquist W, DeWitt P, Muller K. Biochemical changes in humans upon exposure to nitrogen dioxide while at rest. Arch Environ Health. 1981;36(2):53\u20138. Epub 1981/03/01. .", "ArticleIdList": ["7212777"]}, {"Citation": "CDC. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. 3, Chemistry and Toxicology of Cigarette Smoke and Biomarkers of Exposure and Harm. Atlanta: Centers for Disease Control and Prevention (US); National Center for Chronic Disease Prevention and Health Promotion (US); Office on Smoking and Health (US). 2010.", "ArticleIdList": ["21452462"]}, {"Citation": "Crothers K, Daly KR, Rimland D, Goetz MB, Gibert CL, Butt AA, et al.\nDecreased serum antibody responses to recombinant pneumocystis antigens in HIV-infected and uninfected current smokers. Clin Vaccine Immunol. 2011;18(3):380\u20136. doi: 10.1128/CVI.00421-10 ;", "ArticleIdList": ["10.1128/CVI.00421-10", "PMC3067379", "21191078"]}, {"Citation": "ALA. State of the Air Report: American Lung Association; 2016 [cited 2016 21 April]. http://www.lung.org/local-content/california/documents/state-of-the-air/2016/sota-2016_ca-overview.pdf."}], "ReferenceList": []}], "History": [{"Year": "2017", "Month": "2", "Day": "13"}, {"Year": "2017", "Month": "6", "Day": "12"}, {"Year": "2017", "Month": "7", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "7", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "9", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "7", "Day": "10"}], "PublicationStatus": "epublish", "ArticleIdList": ["28692651", "PMC5503245", "10.1371/journal.pone.0180212", "PONE-D-17-05881"]}}], "PubmedBookArticle": []}